カテゴリ： 世界, 医療/バイオ, Market Monitor Global

甲状腺機能低下症治療薬のグローバル市場展望 2023年-2029年：非経口、経皮、経口、その他

■ 英語タイトル：Hypothyroidism Drugs Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8792）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8792
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：116
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[甲状腺機能低下症治療薬のグローバル市場展望 2023年-2029年：非経口、経皮、経口、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の甲状腺機能低下症治療薬市場規模と予測を収録しています。・世界の甲状腺機能低下症治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の甲状腺機能低下症治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の甲状腺機能低下症治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「非経口」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

甲状腺機能低下症治療薬のグローバル主要企業は、Eli Lilly、 Pfizer、 AbbVie、 Novo Nordisk、 Merck KGaA、 Mylan、 Bayer、 Teva、 Novartis、 Abbott、 Roche、 Endo International、 Ipsen、 ANI Pharmaceuticals、 TherapeuticsMDなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、甲状腺機能低下症治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の甲状腺機能低下症治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の甲状腺機能低下症治療薬市場：タイプ別市場シェア、2022年
・非経口、経皮、経口、その他

世界の甲状腺機能低下症治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の甲状腺機能低下症治療薬市場：用途別市場シェア、2022年
・病院、ドラッグストア、その他

世界の甲状腺機能低下症治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の甲状腺機能低下症治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における甲状腺機能低下症治療薬のグローバル売上、2018年-2023年
・主要企業における甲状腺機能低下症治療薬のグローバル売上シェア、2022年
・主要企業における甲状腺機能低下症治療薬のグローバル販売量、2018年-2023年
・主要企業における甲状腺機能低下症治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Eli Lilly、 Pfizer、 AbbVie、 Novo Nordisk、 Merck KGaA、 Mylan、 Bayer、 Teva、 Novartis、 Abbott、 Roche、 Endo International、 Ipsen、 ANI Pharmaceuticals、 TherapeuticsMD

*************************************************************

・調査・分析レポートの概要
甲状腺機能低下症治療薬市場の定義
市場セグメント
世界の甲状腺機能低下症治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の甲状腺機能低下症治療薬市場規模
世界の甲状腺機能低下症治療薬市場規模：2022年 VS 2029年
世界の甲状腺機能低下症治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの甲状腺機能低下症治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の甲状腺機能低下症治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：非経口、経皮、経口、その他
甲状腺機能低下症治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、ドラッグストア、その他
甲状腺機能低下症治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別甲状腺機能低下症治療薬市場規模 2022年と2029年
地域別甲状腺機能低下症治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Eli Lilly、 Pfizer、 AbbVie、 Novo Nordisk、 Merck KGaA、 Mylan、 Bayer、 Teva、 Novartis、 Abbott、 Roche、 Endo International、 Ipsen、 ANI Pharmaceuticals、 TherapeuticsMD
...

Hypothyroidism (underactive thyroid) is a condition in which your thyroid gland doesn’t produce enough of certain crucial hormones.
This report aims to provide a comprehensive presentation of the global market for Hypothyroidism Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hypothyroidism Drugs. This report contains market size and forecasts of Hypothyroidism Drugs in global, including the following market information:
Global Hypothyroidism Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hypothyroidism Drugs Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Hypothyroidism Drugs companies in 2022 (%)
The global Hypothyroidism Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Parenteral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hypothyroidism Drugs include Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Mylan, Bayer, Teva and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hypothyroidism Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hypothyroidism Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Hypothyroidism Drugs Market Segment Percentages, by Type, 2022 (%)
Parenteral
Transdermal
Oral
Others
Global Hypothyroidism Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Hypothyroidism Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Drugstores
Others
Global Hypothyroidism Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Hypothyroidism Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hypothyroidism Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hypothyroidism Drugs revenues share in global market, 2022 (%)
Key companies Hypothyroidism Drugs sales in global market, 2018-2023 (Estimated), (Units)
Key companies Hypothyroidism Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hypothyroidism Drugs, market overview.
Chapter 2: Global Hypothyroidism Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Hypothyroidism Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hypothyroidism Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hypothyroidism Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Hypothyroidism Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hypothyroidism Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hypothyroidism Drugs Overall Market Size
2.1 Global Hypothyroidism Drugs Market Size: 2022 VS 2029
2.2 Global Hypothyroidism Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hypothyroidism Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Hypothyroidism Drugs Players in Global Market
3.2 Top Global Hypothyroidism Drugs Companies Ranked by Revenue
3.3 Global Hypothyroidism Drugs Revenue by Companies
3.4 Global Hypothyroidism Drugs Sales by Companies
3.5 Global Hypothyroidism Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hypothyroidism Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hypothyroidism Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hypothyroidism Drugs Players in Global Market
3.8.1 List of Global Tier 1 Hypothyroidism Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Hypothyroidism Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Hypothyroidism Drugs Market Size Markets, 2022 & 2029
4.1.2 Parenteral
4.1.3 Transdermal
4.1.4 Oral
4.1.5 Others
4.2 By Type – Global Hypothyroidism Drugs Revenue & Forecasts
4.2.1 By Type – Global Hypothyroidism Drugs Revenue, 2018-2023
4.2.2 By Type – Global Hypothyroidism Drugs Revenue, 2024-2029
4.2.3 By Type – Global Hypothyroidism Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Hypothyroidism Drugs Sales & Forecasts
4.3.1 By Type – Global Hypothyroidism Drugs Sales, 2018-2023
4.3.2 By Type – Global Hypothyroidism Drugs Sales, 2024-2029
4.3.3 By Type – Global Hypothyroidism Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Hypothyroidism Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hypothyroidism Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application – Global Hypothyroidism Drugs Revenue & Forecasts
5.2.1 By Application – Global Hypothyroidism Drugs Revenue, 2018-2023
5.2.2 By Application – Global Hypothyroidism Drugs Revenue, 2024-2029
5.2.3 By Application – Global Hypothyroidism Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Hypothyroidism Drugs Sales & Forecasts
5.3.1 By Application – Global Hypothyroidism Drugs Sales, 2018-2023
5.3.2 By Application – Global Hypothyroidism Drugs Sales, 2024-2029
5.3.3 By Application – Global Hypothyroidism Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Hypothyroidism Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Hypothyroidism Drugs Market Size, 2022 & 2029
6.2 By Region – Global Hypothyroidism Drugs Revenue & Forecasts
6.2.1 By Region – Global Hypothyroidism Drugs Revenue, 2018-2023
6.2.2 By Region – Global Hypothyroidism Drugs Revenue, 2024-2029
6.2.3 By Region – Global Hypothyroidism Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Hypothyroidism Drugs Sales & Forecasts
6.3.1 By Region – Global Hypothyroidism Drugs Sales, 2018-2023
6.3.2 By Region – Global Hypothyroidism Drugs Sales, 2024-2029
6.3.3 By Region – Global Hypothyroidism Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Hypothyroidism Drugs Revenue, 2018-2029
6.4.2 By Country – North America Hypothyroidism Drugs Sales, 2018-2029
6.4.3 US Hypothyroidism Drugs Market Size, 2018-2029
6.4.4 Canada Hypothyroidism Drugs Market Size, 2018-2029
6.4.5 Mexico Hypothyroidism Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Hypothyroidism Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Hypothyroidism Drugs Sales, 2018-2029
6.5.3 Germany Hypothyroidism Drugs Market Size, 2018-2029
6.5.4 France Hypothyroidism Drugs Market Size, 2018-2029
6.5.5 U.K. Hypothyroidism Drugs Market Size, 2018-2029
6.5.6 Italy Hypothyroidism Drugs Market Size, 2018-2029
6.5.7 Russia Hypothyroidism Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Hypothyroidism Drugs Market Size, 2018-2029
6.5.9 Benelux Hypothyroidism Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Hypothyroidism Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Hypothyroidism Drugs Sales, 2018-2029
6.6.3 China Hypothyroidism Drugs Market Size, 2018-2029
6.6.4 Japan Hypothyroidism Drugs Market Size, 2018-2029
6.6.5 South Korea Hypothyroidism Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Hypothyroidism Drugs Market Size, 2018-2029
6.6.7 India Hypothyroidism Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Hypothyroidism Drugs Revenue, 2018-2029
6.7.2 By Country – South America Hypothyroidism Drugs Sales, 2018-2029
6.7.3 Brazil Hypothyroidism Drugs Market Size, 2018-2029
6.7.4 Argentina Hypothyroidism Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Hypothyroidism Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Hypothyroidism Drugs Sales, 2018-2029
6.8.3 Turkey Hypothyroidism Drugs Market Size, 2018-2029
6.8.4 Israel Hypothyroidism Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Hypothyroidism Drugs Market Size, 2018-2029
6.8.6 UAE Hypothyroidism Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Hypothyroidism Drugs Major Product Offerings
7.1.4 Eli Lilly Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Eli Lilly Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Hypothyroidism Drugs Major Product Offerings
7.2.4 Pfizer Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Hypothyroidism Drugs Major Product Offerings
7.3.4 AbbVie Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 Novo Nordisk
7.4.1 Novo Nordisk Company Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Hypothyroidism Drugs Major Product Offerings
7.4.4 Novo Nordisk Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Novo Nordisk Key News & Latest Developments
7.5 Merck KGaA
7.5.1 Merck KGaA Company Summary
7.5.2 Merck KGaA Business Overview
7.5.3 Merck KGaA Hypothyroidism Drugs Major Product Offerings
7.5.4 Merck KGaA Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Merck KGaA Key News & Latest Developments
7.6 Mylan
7.6.1 Mylan Company Summary
7.6.2 Mylan Business Overview
7.6.3 Mylan Hypothyroidism Drugs Major Product Offerings
7.6.4 Mylan Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Mylan Key News & Latest Developments
7.7 Bayer
7.7.1 Bayer Company Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Hypothyroidism Drugs Major Product Offerings
7.7.4 Bayer Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Bayer Key News & Latest Developments
7.8 Teva
7.8.1 Teva Company Summary
7.8.2 Teva Business Overview
7.8.3 Teva Hypothyroidism Drugs Major Product Offerings
7.8.4 Teva Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Teva Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Hypothyroidism Drugs Major Product Offerings
7.9.4 Novartis Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Abbott
7.10.1 Abbott Company Summary
7.10.2 Abbott Business Overview
7.10.3 Abbott Hypothyroidism Drugs Major Product Offerings
7.10.4 Abbott Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Abbott Key News & Latest Developments
7.11 Roche
7.11.1 Roche Company Summary
7.11.2 Roche Hypothyroidism Drugs Business Overview
7.11.3 Roche Hypothyroidism Drugs Major Product Offerings
7.11.4 Roche Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Roche Key News & Latest Developments
7.12 Endo International
7.12.1 Endo International Company Summary
7.12.2 Endo International Hypothyroidism Drugs Business Overview
7.12.3 Endo International Hypothyroidism Drugs Major Product Offerings
7.12.4 Endo International Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Endo International Key News & Latest Developments
7.13 Ipsen
7.13.1 Ipsen Company Summary
7.13.2 Ipsen Hypothyroidism Drugs Business Overview
7.13.3 Ipsen Hypothyroidism Drugs Major Product Offerings
7.13.4 Ipsen Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Ipsen Key News & Latest Developments
7.14 ANI Pharmaceuticals
7.14.1 ANI Pharmaceuticals Company Summary
7.14.2 ANI Pharmaceuticals Business Overview
7.14.3 ANI Pharmaceuticals Hypothyroidism Drugs Major Product Offerings
7.14.4 ANI Pharmaceuticals Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.14.5 ANI Pharmaceuticals Key News & Latest Developments
7.15 TherapeuticsMD
7.15.1 TherapeuticsMD Company Summary
7.15.2 TherapeuticsMD Business Overview
7.15.3 TherapeuticsMD Hypothyroidism Drugs Major Product Offerings
7.15.4 TherapeuticsMD Hypothyroidism Drugs Sales and Revenue in Global (2018-2023)
7.15.5 TherapeuticsMD Key News & Latest Developments
8 Global Hypothyroidism Drugs Production Capacity, Analysis
8.1 Global Hypothyroidism Drugs Production Capacity, 2018-2029
8.2 Hypothyroidism Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Hypothyroidism Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hypothyroidism Drugs Supply Chain Analysis
10.1 Hypothyroidism Drugs Industry Value Chain
10.2 Hypothyroidism Drugs Upstream Market
10.3 Hypothyroidism Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hypothyroidism Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ホルモン補充用医薬品のグローバル市場展望 2023年-2029年：エストロゲンホルモン、成長ホルモン、甲状腺ホルモン、テストステロンホルモン
  • イロプロスト薬のグローバル市場展望 2023年-2029年：吸入型、静脈内型
  • うつ病治療薬のグローバル市場展望 2023年-2029年：SSRI、SNRI、その他
  • CAR T細胞型薬剤のグローバル市場展望 2023年-2029年：CD19標的、BCMA標的
  • 脂肪肝治療薬のグローバル市場展望 2023年-2029年：ALD、NAFLD
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8792 )"甲状腺機能低下症治療薬のグローバル市場展望 2023年-2029年：非経口、経皮、経口、その他" (英文：Hypothyroidism Drugs Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。